Brief: Tela Bio Announces U.S. Commercial Launch Of Liquifix – The Only FDA-Approved Liquid Adhesive For Internal Use In Hernia Surgery
21/03/2024 11:37
March 21 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO ANNOUNCES U.S. COMMERCIAL LAUNCH OF LIQUIFIX™ –
THE
ONLY FDA-APPROVED LIQUID ADHESIVE FOR INTERNAL USE IN HERNIA
SURGERY
Source text for Eikon: ID:nGNX6q0Nfw
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview